Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells IGI’s clinically validated BEAT® platform enabled ...
Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells ...
Visit a quote page and your recently viewed tickers will be displayed here.
As of 10:13:40 AM GMT+8. Market Open.
Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells IGI’s clinically validated BEAT ® platform enabled ...
Review quarterly and annual revenue, net income, and cash flow for Lite-On Technology Corp (2301:XTAI) stock through the last fiscal year.
Review the current valuation for Lite-On Technology Corp (2301:XTAI) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.
Visit a quote page and your recently viewed tickers will be displayed here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results